全文获取类型
收费全文 | 1485篇 |
免费 | 102篇 |
国内免费 | 25篇 |
专业分类
儿科学 | 145篇 |
妇产科学 | 14篇 |
基础医学 | 147篇 |
口腔科学 | 66篇 |
临床医学 | 145篇 |
内科学 | 342篇 |
皮肤病学 | 38篇 |
神经病学 | 25篇 |
特种医学 | 328篇 |
外科学 | 83篇 |
综合类 | 21篇 |
预防医学 | 64篇 |
眼科学 | 16篇 |
药学 | 87篇 |
1篇 | |
中国医学 | 1篇 |
肿瘤学 | 89篇 |
出版年
2024年 | 2篇 |
2023年 | 3篇 |
2022年 | 4篇 |
2021年 | 13篇 |
2020年 | 8篇 |
2019年 | 13篇 |
2018年 | 24篇 |
2017年 | 17篇 |
2016年 | 23篇 |
2015年 | 31篇 |
2014年 | 26篇 |
2013年 | 48篇 |
2012年 | 11篇 |
2011年 | 13篇 |
2010年 | 41篇 |
2009年 | 79篇 |
2008年 | 19篇 |
2007年 | 40篇 |
2006年 | 38篇 |
2005年 | 33篇 |
2004年 | 20篇 |
2003年 | 25篇 |
2002年 | 21篇 |
2001年 | 21篇 |
2000年 | 21篇 |
1999年 | 31篇 |
1998年 | 102篇 |
1997年 | 118篇 |
1996年 | 112篇 |
1995年 | 77篇 |
1994年 | 82篇 |
1993年 | 98篇 |
1992年 | 17篇 |
1991年 | 17篇 |
1990年 | 18篇 |
1989年 | 44篇 |
1988年 | 39篇 |
1987年 | 27篇 |
1986年 | 33篇 |
1985年 | 31篇 |
1984年 | 17篇 |
1983年 | 15篇 |
1982年 | 20篇 |
1981年 | 35篇 |
1980年 | 21篇 |
1979年 | 9篇 |
1978年 | 8篇 |
1977年 | 21篇 |
1976年 | 19篇 |
1975年 | 6篇 |
排序方式: 共有1612条查询结果,搜索用时 22 毫秒
991.
Platelets lysed with Triton X-100 contain 3.44 +/- 1.27 (SD) microgram of fibronectin (cold-insoluble globulin) per 10(9) platelets. Fibronectin was partially released from washed whole platelets by collagen or thrombin, and its release by collagen was inhibited by aspirin. Analysis of subcellular fractions obtained by density-gradient centrifugation of disrupted platelets indicated that fibronectin was contained in the alpha granules. Fibrinogen depleted of fibronectin (less than 2 microgram/mg) supported ADP-induced aggregation as effectively as fibrinogen contaminated with this protein, thus reinforcing the generally held view that fibrinogen itself is the necessary protein cofactor in this reaction. 相似文献
992.
Burwinkel B; Shin YS; Bakker HD; Deutsch J; Lozano MJ; Maire I; Kilimann MW 《Human molecular genetics》1996,5(5):653-658
In five cases of X-linked liver glycogenosis subtype 2 (XLG2), we have
identified mutations in the gene encoding the liver isoform of the
phosphorylase kinase alpha subunit (PHKA2). XLG2 is a rare variant of X-
linked phosphorylase kinase (Phk) deficiency of the liver. Whereas in the
more common form of X-linked hepatic Phk deficiency, XLG1, the enzyme's
activity is decreased both in liver and in blood cells, Phk activity in
XLG2 is low in liver but normal or even enhanced in blood cells. Although
missense, nonsense and splicesite mutations in the PHKA2 gene were recently
identified in several cases of XLG1, no mutations have yet been described
for XLG2 and a molecular explanation for the peculiar biochemical phenotype
of XLG2 has been lacking. All mutations found in the present study result
in non-conservative amino acid replacements of residues that are absolutely
conserved between the alpha L, alpha M and beta subunits of Phk [H132P,
H132Y, R186H (twice) and D299G]. Strikingly, in two pairs of cases the
mutations affect the same codon. These results demonstrate that: (i) XLG2
is caused by mutations in PHKA2 and is therefore allelic with XLG1; and
(ii) XLG2 mutations appear to cluster in limited sequence regions or even
individual codons.
相似文献
993.
994.
E Sánchez‐Ferrero E Coto C Beetz J Gámez AI Corao M Díaz J Esteban E del Castillo G Moris J Infante M Menéndez SI Pascual‐Pascual A López de Munaín MJ Garcia‐Barcina V Alvarez 《Clinical genetics》2013,83(3):257-262
Sánchez‐Ferrero E, Coto E, Beetz C, Gámez J, Corao A, Díaz M, Esteban J, del Castillo E, Moris G, Infante J, Menéndez M, Pascual‐Pascual SI, López de Munaín A, Garcia‐Barcina MJ, Alvarez V on behalf of the Genetics of Spastic Paraplegia study group. SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V. Mutations in the SPG7 gene were initially reported in patients with autosomal recessive hereditary spastic paraplegia (HSP). Recent works suggested a dominant effect for some SPG7 mutations. To characterize the SPG7 mutational spectrum in a large cohort of Spanish HSP patients, we sequenced the whole SPG7 gene in a total of 285 Spastic Paraplegia patients. Large gene rearrangements were also ascertained in some patients. We found a total of 14 SPG7 mutations (12 new) in 14 patients; 2 were large deletions. All the mutation carriers had an adult onset age but only five (35%) had a complicated phenotype. We identified a single mutation in 13 patients. Familial analysis suggested a dominant inheritance for one (p.Leu78*) of these mutations. Carriers of the rare p.A510V variant were significantly more frequent in patients vs healthy controls (3% vs 1%), suggesting a pathogenic role for this SPG7 variant. We reported a high frequency of patients with only one SPG7 mutation, and a putative pathogenic role for the p.A510V variant. 相似文献
995.
B Schlenker C Gratzke M Seitz P von Walter D Tilki O Reich D Zaak CG Stief MJ Bader 《European journal of medical research》2010,15(3):121-123
Objectives and aims
To avoid damage to the ureters during bladder neck preparation in radical prostatectomy for prostate cancer, it may be helpful to insert ureteral stents temporarily or to intravenously administer indigo carmine dye for enhanced visualisation of ureteric orifices. We evaluated our bladder neck preserving technique at radical prostatectomy with regard to ureteric injuries.Patients and methods
We analysed 369 consecutive radical prostatectomies operated in our clinic in a bladder neck preserving technique. The following parameters were assessed in this retrospective study: number of prophylactic ureteric stent insertions, application of indigo carmine dye, observed injuries of the ureters by the surgeon, postoperative increase of serum creatinine and postoperative status of kidney ultrasound.Results
In 7/369 prostatectomies (1.90%) a ureteric stent insertion was performed, indigo carmine was not applied to any patient at all, yet no intraoperative injury of a ureter was observed by a surgeon. No revision was necessary due to a ureteral injury within the observation period of one year after surgery. In 17 patients with preoperative normal creatinine value a pathological value was observed on the first postoperative day (mean 1.4 mg/dl). In these patients no consecutive postrenal acute renal failure was observed, no hydronephrosis was monitored by ultrasound and no further intervention was necessary.Conclusions
Bladder neck preserving operation technique does not implicate the need of prophylactic ureteric stent insertions and has no higher incidence of ureteric injuries. 相似文献996.
997.
腹主动脉瘤病因新探讨 总被引:2,自引:0,他引:2
目的 证实家族性因素和遗传性因素在腹主动脉瘤(abdominal aortic aneurysm,AAA)发病中的作用。方法 308例澳大利亚欧洲腹主动脉瘤病人和110例健康对照组以及男女各40例的新生儿对照组。对动脉壁四种重要结构蛋白基因进行等位因基分析。等位基因频率分析采用Sham and Curtis方法。结果 50例AAA病人至少有一例直系亲属患者AAA。在539例存活的同代亲属中,14例 相似文献
998.
999.
Ji Y; Walkowicz MJ; Buiting K; Johnson DK; Tarvin RE; Rinchik EM; Horsthemke B; Stubbs L; Nicholls RD 《Human molecular genetics》1999,8(3):533-542
Transcribed, low-copy repeat elements are associated with the breakpoint
regions of common deletions in Prader-Willi and Angelman syndromes. We
report here the identification of the ancestral gene ( HERC2 ) and a family
of duplicated, truncated copies that comprise these low-copy repeats. This
gene encodes a highly conserved giant protein, HERC2, that is distantly
related to p532 (HERC1), a guanine nucleotide exchange factor (GEF)
implicated in vesicular trafficking. The mouse genome contains a single
Herc2 locus, located in the jdf2 (juvenile development and fertility-2)
interval of chromosome 7C. We have identified single nucleotide splice
junction mutations in Herc2 in three independent
N-ethyl-N-nitrosourea-induced jdf2 mutant alleles, each leading to exon
skipping with premature termination of translation and/or deletion of
conserved amino acids. Therefore, mutations in Herc2 lead to the
neuromuscular secretory vesicle and sperm acrosome defects, other
developmental abnormalities and juvenile lethality of jdf2 mice. Combined,
these findings suggest that HERC2 is an important gene encoding a GEF
involved in protein trafficking and degradation pathways in the cell.
相似文献
1000.
N Schoenmakers Y Sun B Bak ASP van Trotsenburg W Oostdijk P Voshol E Cambridge JK White P le Tissier SNM Gharavy JP Martinez-Barbera WH Stokvis-Brantsma T Vulsma MJ Kempers L Persani I Campi M Bonomi P Beck-Peccoz K Chatterjee 《Lancet》2013
BackgroundCongenital central hypothyroidism occurs either as isolated thyroid-stimulating hormone (TSH) deficiency or in conjunction with other pituitary hormone deficits. Undetected central hypothyroidism is associated with developmental delay in children and adverse cardiometabolic sequelae in adults. Hitherto, mutations in the thyrotropin-releasing hormone receptor gene (TRHR) or the TSHb subunit gene (TSHB) are the only known causes of isolated TSH deficiency.MethodsUsing whole exome and candidate gene sequencing, we have studied 11 unrelated families with males exhibiting isolated TSH deficiency, testicular enlargement, and variably low serum prolactin levels.FindingsWe have identified eight distinct mutations and two whole gene deletions disrupting the X-linked immunoglobulin superfamily member 1 gene (IGSF1) in affected males. IGSF1 encodes a pituitary-enriched plasma membrane glycoprotein; disease-associated mutations block trafficking of IGSF1 from the endoplasmic reticulum to the membrane, consistent with loss-of-protein function. Adult male IGSF1 null mice exhibit central hypothyroidism with decreased pituitary TSH content and circulating T3 levels; TSH secretion in response to TRH is blunted and pituitary TRHR mRNA levels are decreased, suggesting that impaired TRH signalling may provide the basis for hypothyroidism.InterpretationOur observations delineate a novel X-linked syndrome in which loss-of-function mutations in IGSF1 cause central hypothyroidism, testicular enlargement, and variable prolactin deficiency, and identify a previously unsuspected role for IGSF1 in hypothalamic-pituitary control of thyroid and testicular function. Variable biochemical penetrance in these families highlights the importance of genetic ascertainment in this syndrome, so that asymptomatic affected individuals can benefit from early initiation of thyroxine treatment.FundingWellcome Trust and National Institute for Health Research Biomedical Research Centre. 相似文献